Skip to main content

02.04.2019 | Original Article

Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age

verfasst von: Derya Tilki, Valentin Maurer, Raisa S. Pompe, Felix K. Chun, Felix Preisser, Alexander Haese, Markus Graefen, Hartwig Huland, Philipp Mandel

Erschienen in: World Journal of Urology

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Age is an important prognostic factor for functional and oncological outcomes after radical prostatectomy (RP). Considering the long life-expectancy of young patients (≤ 45 years), it remains important to examine their outcomes.

Methods

Of 16.049 patients who underwent RP between 01/2006 and 12/2014 at the Martini-Klinik Prostate Cancer Center, 119 (0.7%) were ≤ 45. Known prognosticators were compared according to patient age at RP (categorical as ≤ 45, > 45 and ≤ 65, > 65 years). Kaplan–Meier plots and Cox-regressions analyzed oncological outcomes [biochemical recurrence (BCR)-free survival and metastasis-free survival (MFS)]. Logistic regressions were used for functional outcome. Urinary continence (UC) was defined as the use of 0 or 1 safety pad/day and potency as an IIEF-5 score of ≥ 18.

Results

Compared to their older counterparts, patients ≤ 45 years had more favorable tumor characteristics. Of all patients aged ≤ 45 years, 89% underwent bilateral and 9.3% unilateral nerve-sparing procedure. Five year BCR-free survival and MFS were 80.2% and 98.7% for patients ≤ 45 years, 72.8% and 95.0% for patients > 45 and ≤ 65 years and 70.5% and 94.9% for patients > 65 years. For the same groups, 1-year UC-rates were 97.4%, 89.4%, and 84.7% while 1.3%, 8.2%, and 11.6% used 1–2 pads/24 h. At 1-year, 75.6%, 58.6%, and 45.3% of preoperatively potent patients who underwent bilateral nerve-sparing were considered potent. Younger age was an independent predictor of favorable functional outcome also in multivariable analysis.

Conclusions

Patients aged ≤ 45 years had more favorable tumor characteristics and oncological outcomes. Moreover, younger patients should be counseled about the excellent postoperative continence and potency rates.
Literatur
2.
3.
Zurück zum Zitat Basu S, Singh SK, Singh U (2016) A study of age distribution of prostate cancer detection. J Data Sci 14:539–552 Basu S, Singh SK, Singh U (2016) A study of age distribution of prostate cancer detection. J Data Sci 14:539–552
4.
Zurück zum Zitat Herget KA et al (2016) Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. Cancer Med 5(1):136–141CrossRef Herget KA et al (2016) Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score. Cancer Med 5(1):136–141CrossRef
5.
Zurück zum Zitat Becker A et al (2014) Functional and oncological outcomes of patients aged < 50 years treated with radical prostatectomy for localised prostate cancer in a European population. BJU Int 114(1):38–45CrossRef Becker A et al (2014) Functional and oncological outcomes of patients aged < 50 years treated with radical prostatectomy for localised prostate cancer in a European population. BJU Int 114(1):38–45CrossRef
6.
Zurück zum Zitat Mottet N, van den Bergh RCN, Briers E et al (2019) EAU - EANM - ESTRO - ESUR - SIOG guidelines on prostate cancer. European Association of Urology 2019, EAU Guidelines Office, Arnhem, The Netherlands Mottet N, van den Bergh RCN, Briers E et al (2019) EAU - EANM - ESTRO - ESUR - SIOG guidelines on prostate cancer. European Association of Urology 2019, EAU Guidelines Office, Arnhem, The Netherlands
7.
Zurück zum Zitat Mohler J, Kantoff P, Armstrong A et al (2014) Prostate cancer, Version 2.2014. J Natl Compr Canc Netw 12:686–718CrossRef Mohler J, Kantoff P, Armstrong A et al (2014) Prostate cancer, Version 2.2014. J Natl Compr Canc Netw 12:686–718CrossRef
8.
Zurück zum Zitat Sanda MG, Chen RC, Crispino T et al (2017) Clinically localized prostate cancer: AUA/ASTRO/SUO guideline, American Urological Association 2017 Sanda MG, Chen RC, Crispino T et al (2017) Clinically localized prostate cancer: AUA/ASTRO/SUO guideline, American Urological Association 2017
9.
Zurück zum Zitat Mandel P, Graefen M, Michl U et al (2015) The effect of age on functional outcomes after radical prostatectomy. Urol Oncol 33:e11–e18CrossRef Mandel P, Graefen M, Michl U et al (2015) The effect of age on functional outcomes after radical prostatectomy. Urol Oncol 33:e11–e18CrossRef
10.
Zurück zum Zitat Mandel P et al (2016) Tumor characteristics and oncologic outcome after radical prostatectomy in men 75 years old or older. J Urol 196(1):89–94CrossRef Mandel P et al (2016) Tumor characteristics and oncologic outcome after radical prostatectomy in men 75 years old or older. J Urol 196(1):89–94CrossRef
11.
Zurück zum Zitat Gandaglia G et al (2014) The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis. Eur J Surg Oncol 40(12):1706–1715CrossRef Gandaglia G et al (2014) The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis. Eur J Surg Oncol 40(12):1706–1715CrossRef
12.
Zurück zum Zitat Labanaris A, Vahudin Z, Witt J (2012) Robotic-assisted radical prostatectomy in men ≤ 50 years of age. Surgical, oncological and functional outcomes. Anticancer Res 32:2097–2101PubMed Labanaris A, Vahudin Z, Witt J (2012) Robotic-assisted radical prostatectomy in men ≤ 50 years of age. Surgical, oncological and functional outcomes. Anticancer Res 32:2097–2101PubMed
13.
Zurück zum Zitat Rouprêt M et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67(5):1028–1032CrossRef Rouprêt M et al (2006) Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. Urology 67(5):1028–1032CrossRef
14.
Zurück zum Zitat Moses KA et al (2014) Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy. BMC Urol 14(1):98CrossRef Moses KA et al (2014) Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy. BMC Urol 14(1):98CrossRef
15.
Zurück zum Zitat Loeb S et al (2008) Progression after radical prostatectomy for men in their thirties compared to older men. BJU Int 101(12):1503–1506CrossRef Loeb S et al (2008) Progression after radical prostatectomy for men in their thirties compared to older men. BJU Int 101(12):1503–1506CrossRef
16.
Zurück zum Zitat Freedland SJ et al (2004) Do younger men have better biochemical outcomes after radical prostatectomy? Urology 63(3):518–522CrossRef Freedland SJ et al (2004) Do younger men have better biochemical outcomes after radical prostatectomy? Urology 63(3):518–522CrossRef
17.
Zurück zum Zitat Hospital, O.S.U.C.C.C.J.C. and S.R. Institute (2007) Prostate cancer early detection. J Natl Compr Cancer Netw 5(7):714CrossRef Hospital, O.S.U.C.C.C.J.C. and S.R. Institute (2007) Prostate cancer early detection. J Natl Compr Cancer Netw 5(7):714CrossRef
18.
Zurück zum Zitat Budaus L, Isbarn H, Schlomm T et al (2009) Current technique of open intrafascial nerve-sparing retropubic prostatectomy. Eur Urol 56:317–324CrossRef Budaus L, Isbarn H, Schlomm T et al (2009) Current technique of open intrafascial nerve-sparing retropubic prostatectomy. Eur Urol 56:317–324CrossRef
19.
Zurück zum Zitat Gleason D, Mellinger G (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58–64CrossRef Gleason D, Mellinger G (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58–64CrossRef
20.
Zurück zum Zitat Epstein JI et al (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244–252PubMed Epstein JI et al (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244–252PubMed
21.
Zurück zum Zitat Greco K, Meeks J, Wu S et al (2009) Robot-assisted radical prostatectomy in men aged ≥ 70 years. BJU Int 104:1492–1495CrossRef Greco K, Meeks J, Wu S et al (2009) Robot-assisted radical prostatectomy in men aged ≥ 70 years. BJU Int 104:1492–1495CrossRef
22.
Zurück zum Zitat Labanaris A, Witt J, Zugor V (2012) Robotic-assisted radical prostatectomy in men ≥ 75 years of age. Surgical, oncological and functional outcomes. Anticancer Res 35:2085–2089 Labanaris A, Witt J, Zugor V (2012) Robotic-assisted radical prostatectomy in men ≥ 75 years of age. Surgical, oncological and functional outcomes. Anticancer Res 35:2085–2089
23.
Zurück zum Zitat Lin DW, Porter M, Montgomery B (2009) Treatment and survival outcomes in young men diagnosed with prostate cancer. Cancer 115(13):2863–2871CrossRef Lin DW, Porter M, Montgomery B (2009) Treatment and survival outcomes in young men diagnosed with prostate cancer. Cancer 115(13):2863–2871CrossRef
24.
Zurück zum Zitat Hong SK et al (2011) Younger patients have poorer biochemical outcome after radical prostatectomy in high-risk prostate cancer. Asian J Androl 13:719–723CrossRef Hong SK et al (2011) Younger patients have poorer biochemical outcome after radical prostatectomy in high-risk prostate cancer. Asian J Androl 13:719–723CrossRef
25.
Zurück zum Zitat Pompe RS et al (2018) Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤ 50 years: a population-based study. Prostate Cancer Prostate Dis 21(1):71–77CrossRef Pompe RS et al (2018) Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤ 50 years: a population-based study. Prostate Cancer Prostate Dis 21(1):71–77CrossRef
26.
Zurück zum Zitat Samadi DB et al (2017) Clinicopathological, functional, and immediate oncologic outcome assessment in men aged ≤ 50 years with prostate cancer after robotic prostatectomy. Urol Oncol Seminar Original Investig 35(1):30.e17–30.e24CrossRef Samadi DB et al (2017) Clinicopathological, functional, and immediate oncologic outcome assessment in men aged ≤ 50 years with prostate cancer after robotic prostatectomy. Urol Oncol Seminar Original Investig 35(1):30.e17–30.e24CrossRef
27.
Zurück zum Zitat Tan L et al (2018) Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy. Prostate Int 6(1):31–35CrossRef Tan L et al (2018) Survival outcomes of younger men (< 55 years) undergoing radical prostatectomy. Prostate Int 6(1):31–35CrossRef
28.
Zurück zum Zitat Gielchinsky I et al (2018) Prostate cancer in 432 men aged < 50 years in the prostate-specific antigen era: a new outlook. BJU Int 122(S5):35–41CrossRef Gielchinsky I et al (2018) Prostate cancer in 432 men aged < 50 years in the prostate-specific antigen era: a new outlook. BJU Int 122(S5):35–41CrossRef
29.
Zurück zum Zitat Suardi N, Moschini M, Gallina A et al (2013) Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int 111:717–722CrossRef Suardi N, Moschini M, Gallina A et al (2013) Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery. BJU Int 111:717–722CrossRef
30.
Zurück zum Zitat Michl U et al (2016) Nerve-sparing surgery technique, not the preservation of the neurovascular bundles, leads to improved long-term continence rates after radical prostatectomy. Eur Urol 69(4):584–589CrossRef Michl U et al (2016) Nerve-sparing surgery technique, not the preservation of the neurovascular bundles, leads to improved long-term continence rates after radical prostatectomy. Eur Urol 69(4):584–589CrossRef
31.
Zurück zum Zitat Schlomm T et al (2012) Neurovascular structure-adjacent Frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11 069 consecutive patients. Eur Urol 62(2):333–340CrossRef Schlomm T et al (2012) Neurovascular structure-adjacent Frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11 069 consecutive patients. Eur Urol 62(2):333–340CrossRef
32.
Zurück zum Zitat Adam M et al (2017) Functional outcomes and quality of life after radical prostatectomy only versus a combination of prostatectomy with radiation and hormonal therapy. Eur Urol 71(3):330–336CrossRef Adam M et al (2017) Functional outcomes and quality of life after radical prostatectomy only versus a combination of prostatectomy with radiation and hormonal therapy. Eur Urol 71(3):330–336CrossRef
Metadaten
Titel
Tumor characteristics, oncological and functional outcomes after radical prostatectomy in very young men ≤ 45 years of age
verfasst von
Derya Tilki
Valentin Maurer
Raisa S. Pompe
Felix K. Chun
Felix Preisser
Alexander Haese
Markus Graefen
Hartwig Huland
Philipp Mandel
Publikationsdatum
02.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02740-8

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.